HOME >> BIOLOGY >> NEWS
Biogen Idec acquires Brandeis spin-out

WALTHAM, MassSyntonix Pharmaceuticals, a spin-out company formed by Brandeis University, Brigham and Women's Hospital, and Children's Hospital Boston announced today that it was acquired by biotech giant Biogen Idec (NASDAQ: BIIB - News). Syntonix, a privately held biopharmaceutical company, was founded in 1997 based on breakthrough discoveries from the laboratories of Neil Simister, Ph.D. (Brandeis), Wayne Lencer, M.D. (Children's), and Richard S. Blumberg, M.D. (Brigham). Their research harnesses the human body's natural immunological pathways for novel methods of drug delivery.

"We founded Syntonix with the hope of translating our basic discoveries into improvements in healthcare. The company developed and expanded our technologies to the stage where they have preclinical candidates for treating hemophilia and infertility. Biogen Idec's acquisition is an excellent outcome because they have the expertise in manufacturing and development to bring these drugs to the clinic," said Neil Simister, a Brandeis biology professor and one of Syntonix' founders.

"Brandeis University has a very strong science faculty. This acquisition by Biogen Idec is evidence of the strength of Brandeis' technology. Brandeis has spun-out a number of companies; however, this is the first to be acquired by a large biotech. We are very pleased to have Biogen Idec as our new licensee and we look forward to their success with this technology," said Irene Abrams, the Director of the Office of Technology Licensing at Brandeis University.

Syntonix's lead product, FIX:Fc, is a proprietary long-acting factor IX product for the treatment of hemophilia B. It has the potential to reduce the frequency of intravenous injections required for disease management. Syntonix is expected to file an investigational new drug application with the Food and Drug Administration for FIX:Fc in 2007.

The transaction closed on Januray 31, 2007. In connection with the closing of th
'"/>

Contact: Laura Gardner
gardner@brandeis.edu
781-736-4204
Brandeis University
31-Jan-2007


Page: 1 2 3

Related biology news :

1. Macrochem acquires option to license pexiganan
2. Wiley acquires publications from Carpe Diem Communications
3. Ossur hf. acquires the Gibaud Group in France
4. Springer acquires BioTribune Magazine and Biotribune.com
5. Stevens Davidson Laboratory acquires new research vessel
6. Accentia Biopharmaceuticals acquires exclusive license
7. Ossur acquires US orthotics company Royce Medical
8. Molecular Profiling Institute, Inc. acquires NanoBiomics, Inc.
9. New Brandeis research sheds light on memory by erasing it
10. National Academy of Sciences elects 2 Brandeis University scientists to membership
11. Brandeis and Brigham and Womens Hospital license technology for Gauchers to Amicus Therapeutics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2020)... ... August 21, 2020 , ... The ... been published and is now available on the company’s global website. Crystallography Times—an ... analysis community, presenting current news and crystallographic research. , The latest issue ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary ... Both Roche and J&J have annual Research and Development spending in excess of ...
(Date:8/3/2020)... ... August 03, 2020 , ... Accumen Inc. ... with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits nationally. ... supply chain for more than 10 years. Early in the COVID-19 crisis, we ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... (PRWEB) , ... August 12, 2020 , ... ... Inc. (EMMA International), a global leader in FDA compliance consulting has been ... nation’s fastest-growing private companies. The list represents a unique look at the most ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health ... growth, , Known as MediVet Biologics since its formation in ... The new Ardent Animal Health will build on its base of innovative therapies ...
(Date:7/31/2020)... ... July 29, 2020 , ... Diversified Technologies, Inc. has introduced ... configured to drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter ... in a push-pull configuration; yielding fast fall time for a capacitive load. These ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... eSource has ... inefficiencies. This webinar will cover the history of eSource, the reasons it did not ... EMR/EHR to wearables, to site source, the industry is moving towards capturing data electronically ...
Breaking Biology Technology:
Cached News: